[{"Assets_0_FY_USD":2896787000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":244685000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":247757000.0,"StockholdersEquityConverted_0_FY_USD":1338191000.0,"StockholdersEquity_0_FY_USD":1156582000.0,"RevenuesConverted_4_FY_USD":1702177000.0,"RevenuesConverted_1_FY_USD":458706000.0,"NetIncomeLossConverted_4_FY_USD":-112052000.0,"NetIncomeLossConverted_1_FY_USD":32945000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":236103000.0,"EarningsPerShareDiluted_4_FY_USD":-0.46,"EarningsPerShareDiluted_1_FY_USD":0.13,"EarningsPerShareBasic_4_FY_USD":-0.46,"EarningsPerShareBasic_1_FY_USD":0.13,"CommonStockSharesOutstanding_0_FY_shares":248300517.0,"CommonStockSharesConverted_0_FY_shares":248300517.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":245454000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":244685000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170223"}]